PTIX Stock Analysis Overview
What this means: InvestorsObserver gives Protagenic Therapeutics Inc (PTIX) an overall rank of 29, which is below average. Protagenic Therapeutics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 29 means that 71% of stocks appear more favorable to our system.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
PTIX Fundamental Analysis
Upgrade to Premium to unlock Fundamental Ranking
PTIX Short-Term Technical Analysis
Upgrade to Premium to unlock Short-Term Technical Ranking
PTIX Long-Term Technical Analysis
Upgrade to Premium to unlock Long-Term Technical Ranking
PTIX Analyst Ranking
Upgrade to Premium to unlock Analyst Ranking Analysis
PTIX Valuation Ranking Analysis
Upgrade to Premium to unlock Valuation Ranking
PTIX Stock Sentiment Analysis
Upgrade to Premium to unlock Stock Sentiment Ranking
PTIX Stock Analysis Overview
What this means: InvestorsObserver gives Protagenic Therapeutics Inc (PTIX) an overall rank of 29, which is below average. Protagenic Therapeutics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 29 means that 71% of stocks appear more favorable to our system.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.